CGO.bio was founded to enable development of the next generation of modifiers of the intestinal epithelium to modulate gut health and disease. Our team comprises blends international experts in Gastroenterology, Children's Health, Stem Cell Technology and Medical Genetics.

The CGO.bio team has developed proprietary insights into key modifiers of inflammation of the intestine that present exciting and highly promising targets for the personalised therapy

At CGO, we are committed to ethical and responsible biotech research and development. We believe in putting patients first, and we are dedicated to developing products and therapies that are safe, effective, and accessible to all.